 <h1>Congratulations! 🎉 </h1>
    <p style="color:#637381;">All done! You’ve completed another milestone.</p>

To continue, enter your details to log in.

We’ve sent a 6‑digit code to #MAIL_ADDRESS#\nPlease check your inbox or spam folder and enter the code below to continue.

Verification code sent

Thank you for the payment. You can now access {collectionName} by simply clicking the button below.

Yes, you’ve successfully ordered! 🎉

Unlock This Exclusive Course

It seems that your email address is not currently on the authorized access list. Please ensure you are using the email address that was invited, or contact the content owner for assistance.

Verification Required for Access

Course Overview

What is this course about?

Who is this mini-course for?

Teaching goals (10)

Learning objectives (measurable, for the module header)

Slide-by-Slide Presentation

Slide 1 — Opening Hook (45 sec)

Slide 2 — Concept Simplified (60 sec)

Slide 3 — Case Study with Characters and Dialogue (90 sec)

Slide 4 — Practical Application (60 sec)

Slide 5 — Knowledge Check + Takeaways (45 sec)

Required Additions

Five Multiple-Choice Questions (with answers and explanation)

Ten-Point Audit / Inspection Checklist

Ten Key Concepts from the Module

Quiz

Quiz 1: Fundamentals of Degradation Products

Quiz 2: Understanding Thresholds

Quiz 3: Navigating the Decision Tree

Quiz 4: Identifying Common Errors

Quiz 5: Risk-Based Decision Making

Survey/Feedback

Course Effectiveness Survey

Application and Improvement Survey

Welcome to "Implementing the ICH Q3B(R2) Identification and Qualification Decision Tree," a comprehensive online course designed for pharmaceutical professionals. Unchecked degradation products can severely impact patient safety and lead to critical regulatory inspection failures.

Welcome to "Implementing the ICH Q3B(R2) Identification and Qualification Decision Tree," a comprehensive online course designed for pharmaceutical professionals. Unchecked degradation products can severely impact patient safety and lead to critical regulatory inspection failures. This course provides an in-depth exploration of the ICH Q3B(R2) guidelines, focusing specifically on the identification and qualification of degradation products in drug products. Throughout this training, you will learn how to differentiate between impurities covered by Q3A and degradation products covered by Q3B, ensuring your product control strategy is robust and compliant. We will guide you step-by-step through the complex decision tree, breaking down critical thresholds for reporting, identification, and qualification based on maximum daily dose and the dose dependency principle. Through realistic case studies, interactive slide presentations, and practical applications, you will master how to handle borderline situations, out-of-trend data, and even when to invoke ICH M7 for potentially mutagenic degradants. By the end of this course, you will be equipped with a 10-point audit and inspection checklist to keep your specifications defensible during regulatory audits. Whether you are involved in batch release, stability data review, or CMC submissions, this course will empower you to make risk-based, compliant decisions with confidence. Enroll today to safeguard your drug products and streamline your regulatory compliance workflows.

119. Implementing the ICH Q3B(R2) Identification and Qualification Decision Tree

<div class="simple-box-wrapper">
    <div class="simple-box">
        <div class="column">
            <p>The management of degradation products in pharmaceutical drug products is a critical component of ensuring patient safety, maintaining product efficacy, and securing favorable regulatory inspection outcomes. The ICH Q3B(R2) guideline establishes a rigorous, structured framework specifically for addressing these degradation products, which must be carefully distinguished from the drug substance impurities governed by ICH Q3A. This course delivers an advanced, comprehensive examination of the ICH Q3B(R2) Identification and Qualification Decision Tree. It is specifically designed for Quality Assurance reviewers, Quality Control analysts, Regulatory Affairs (CMC) specialists, and manufacturing leads who are responsible for generating stability data, setting product specifications, and executing batch release decisions. By bridging the gap between raw chromatographic purity testing and overarching regulatory requirements, the curriculum ensures that cross-functional teams can confidently navigate complex compliance landscapes.</p>

<p>Throughout this program, professionals will systematically explore the fundamental concepts of reporting, identification, and qualification thresholds, with a strong emphasis on the dose-dependency principle and the critical "whichever is lower" rule. The course transitions from theoretical guidelines to practical application through realistic case studies, enabling participants to apply decision tree logic to borderline stability findings and out-of-trend data. Additionally, the modules address high-risk scenarios, such as invoking ICH M7 for potentially mutagenic degradants, and highlight common industry errors to prevent non-compliant shortcuts. Supported by targeted knowledge checks and a robust ten-point audit checklist, this training equips laboratory and quality personnel with the defensible rationales and best practices required to safeguard product control strategies during stringent regulatory inspections.</p>
        </div>
    </div>
</div>
